OIG safe harbor rules now explicitly allow technology companies to participate in Value-Based Enterprises, creating compliant partnership pathways

Acuity's integrated platform addresses all VBC requirements: RPM, ambient documentation, clinical intelligence, and care coordination

Pilot targeting 50% reduction in CHF readmissions with validated 12-month implementation roadmap. Full ROI also obtained from remote patient monitoring (RPM)

• OIG safe harbor rules explicitly allow technology companies to participate in Value-Based Enterprises (VBEs)
• Eliminates Anti-Kickback Act violations when technology is tied to value-based goals
• Creates compliant pathway for care coordination partnerships
• Removes traditional barriers between technology vendors and healthcare providers

• Technology platform becomes integral part of care delivery model
• Shared data and resources across all VBE participants
• Joint accountability for patient outcomes and cost targets
• Protection under federal safe harbor guidelines

• Initial technology enablement partnership
• Performance-based fee structures tied to outcomes
• Graduated risk sharing as proven results demonstrate value
• Full risk partnership potential with established track record

• Deeper market penetration through aligned incentives
• Sustainable revenue model beyond traditional SaaS
• Competitive differentiation through outcome accountability
• Platform for scaling across multiple VBE partnerships

• VBE must have legitimate value-based purpose focused on patient outcomes
• Technology contributions must be directly related to achieving value-based goals
• No payments or incentives for referrals outside the VBE arrangement
• Regular monitoring and documentation of compliance activities

• Technology provided as in-kind contribution to VBE
• Shared savings distribution based on outcome achievements
• Risk corridor arrangements to limit downside exposure
• Performance bonuses tied to quality metrics and cost reductions

• Seamless bi-directional data exchange with EHRs
• FHIR, HL7, and C-CDA standards compliance
• Real-time admission, medication, and OASIS data synchronization
• Eliminates redundant data entry across care settings

• Connected devices: weight scales, BP cuffs, pulse oximeters
• Real-time alert system with personalized thresholds
• Early intervention protocols for CHF decompensation
• Medicare-reimbursable chronic care management codes

• AI-powered risk stratification and predictive modeling
• Clinical decision support at point of care
• Real-time outcomes tracking and Mixture of Experts (MoE) AI system
• Evidence-based therapy optimization prompts

• Ambient OASIS-E assessment documentation
• 80-90% reduction in clinician documentation time
• Voice command integration for hands-free operation
• Improved accuracy and completeness of clinical records

• Centralized population health management
• Real-time patient status and alert monitoring
• Exception-based care coordination workflows
• Performance metrics and quality oversight tools

• Mobile app with educational resources and reminders
• Symptom reporting and virtual visit capabilities
• Secure messaging and family caregiver support
• Gamification elements to drive adherence

• Existing Acuity deployment infrastructure
• Favorable regulatory environment for VBEs
• Home health agencies provide care nationwide, reaching patients wherever they live
• Mounting reimbursement pressure from both Traditional Medicare and Medicare Advantage plans

• 500-2,000 patient census home health agency
• Existing hospital partnerships
• KanTime EMR implementation (seamless integration)
• Quality-focused leadership team

• Only platform with native OASIS-E ambient documentation
• KanTime integration
• Proprietary risk stratification AI
• FDA-cleared RPM device ecosystem
• Clinical Benchmark: Scored proposal for NIH Phase I grant for hospitalization prediction of CHF with our proprietary AI system

• Existing deployment infrastructure vs. 18-24 month competitor builds
• Proven regulatory pathway (OIG safe harbor compliance)
• Ready clinical protocols for CHF population
• Established payer relationships for reimbursement

• Complex regulatory landscape (Anti-Kickback, Stark Law)
• High switching costs for incumbent EMR systems
• Clinical workflow integration complexity
• Long sales cycles (12-18 months average)

• First-mover advantage in VBC transformation market
• Regulatory tailwinds supporting technology enablement
• AI-native technology platform ready for scale
• Clear path to $100M+ revenue within 36 months

• 25% reduction in CHF readmissions
• 40% improvement in documentation efficiency
• 90%+ patient satisfaction scores
• 15%+ cost savings for payer partners